Similar Articles
Nationwide prescription big data: An evaluation of injectable, oral, and monoclonal antibody disease-modifying therapies in multiple sclerosis
Esra Taşkıran, Bilgin Öztürk, Naim Ata, Şuayip Birinci
DOI: 10.55697/tnd.2026.622
Issue: 2026, Volume 32 - Issue 1
1407
948
Six-month prognosis of acute ischemic stroke in patients with cancer: A prospective study
Hasan Hüseyin Kozak, Murat Araz, Ayşenur İnce, Ahmet Buğrul
DOI: 10.55697/tnd.2026.627
Issue: 2026, Volume 32 - Issue 2
1651
707
Recorded diagnosis-based incidence and point prevalence of multiple sclerosis in Azerbaijan between 2013 and 2022: Estimates from a national referral center registry
Rahim Aliyev, Ayten Mammadbayli, Rana Shiraliyeva
DOI: 10.55697/tnd.2026.749
Issue: 2026, Volume 32 - Issue 3
664
325